Oxycodone Abuse in New York City: Characteristics of Intravenous and Intranasal Users
2011; Wiley; Volume: 20; Issue: 3 Linguagem: Inglês
10.1111/j.1521-0391.2011.00120.x
ISSN1521-0391
AutoresJermaine D. Jones, Suzanne K. Vosburg, Jeanne M. Manubay, Sandra D. Comer,
Tópico(s)Pain Management and Opioid Use
ResumoThe American Journal on AddictionsVolume 20, Issue 3 p. 190-195 Oxycodone Abuse in New York City: Characteristics of Intravenous and Intranasal Users Jermaine D. Jones PhD, Jermaine D. Jones PhD Division on Substance Abuse, New York State Psychiatric Institute, New York, New York Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New YorkSearch for more papers by this authorSuzanne K. Vosburg PhD, Suzanne K. Vosburg PhD Division on Substance Abuse, New York State Psychiatric Institute, New York, New York Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New YorkSearch for more papers by this authorJeanne M. Manubay MD, Jeanne M. Manubay MD Division on Substance Abuse, New York State Psychiatric Institute, New York, New York Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New YorkSearch for more papers by this authorSandra D. Comer PhD, Sandra D. Comer PhD Division on Substance Abuse, New York State Psychiatric Institute, New York, New York Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New YorkSearch for more papers by this author Jermaine D. Jones PhD, Jermaine D. Jones PhD Division on Substance Abuse, New York State Psychiatric Institute, New York, New York Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New YorkSearch for more papers by this authorSuzanne K. Vosburg PhD, Suzanne K. Vosburg PhD Division on Substance Abuse, New York State Psychiatric Institute, New York, New York Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New YorkSearch for more papers by this authorJeanne M. Manubay MD, Jeanne M. Manubay MD Division on Substance Abuse, New York State Psychiatric Institute, New York, New York Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New YorkSearch for more papers by this authorSandra D. Comer PhD, Sandra D. Comer PhD Division on Substance Abuse, New York State Psychiatric Institute, New York, New York Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New YorkSearch for more papers by this author First published: 08 March 2011 https://doi.org/10.1111/j.1521-0391.2011.00120.xCitations: 20 Address correspondence to Dr. Jones, Division on Substance Abuse, New York State Psychiatric Institute, 1051 Riverside Drive (Unit 120), New York, NY 10032. E-mail: [email protected]. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Abstract This pilot study sought to characterize typical nonmedical oxycodone use in the New York Metropolitan area. Accordingly, a clinical interview was administered to 25 intranasal (IN) and 25 intravenous (IV) oxycodone abusers to capture demographics and patterns of use within the region. IN and IV abusers shared a number of similar characteristics including age, proportion of men and women, criminal history, drug use history, and current recreational drug use. However, the two populations also differed in a number of aspects. IV oxycodone users had lower rates of employment, earlier onset of illicit drug use, and more current heroin use. Although IN users reported somewhat more frequent use of oxycodone weekly, IV users were more likely to supplement their oxycodone use with other opioid drugs, most notably heroin. Additional research is needed to confirm these observed differences, yet these data may assist treatment efforts by providing information to guide targeted treatment and population-specific interventions. (Am J Addict 2011; 00:1–6) REFERENCES 1 Gilson AM, Ryan KM, Joranson DE, et al. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Symptom Manage. 2004; 28: 176–188. 2 SAMHSA. Results from the 2004 National Survey on Drug Use and Health: National Findings. Rockville , MD : Office of Applied Studies; 2005. DHHS Publication No. SMA 05-4062, NSDUH Series H-28. Available at: http://www.oas.samhsa.gov/NSDUH/2k4NSDUH/2k4results/2k4results.htm. Accessed January 26, 2010. 3 SAMHSA. The New DAWN Report: Emergency Department Visits Involving Nonmedical Use of Selected Pharmaceuticals. Rockville , MD : Office of Applied Studies; 2006. Issue 23. Available at: https://dawninfo.samhsa.gov/files/TNDR07EDvisitsNonmedicalUse.htm. Accessed August 23, 2009. 4 Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002–2004. J Pain. 2005; 6: 662–672. 5 SAMHSA. Federal Report Shows New Nonmedical Users of Prescription Pain Relievers Outnumbered New Marijuana Users between 2002 and 2004. 2006. Available at: http://www.samhsa.gov/newsroom/advisories/061102misuse5701.aspx. Accessed February 18, 2009. 6 SAMHSA. Results from the 2007 National Survey on Drug Use and Health: National Findings. Rockville , MD : Office of Applied Studies; 2008. Publication No. SMA 08-4343. NSDUH Series H-34, DHHS. 7 Becker WC, Sullivan LE, Tetrault JM, et al. Non-medical use, abuse and dependence on prescription opioids among US adults: Psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008; 94: 38–47. 8 US Department of Health and Human Services. The NSDUH report: Nonmedical oxycodone users: A comparison with heroin. 2005. Available at: http://www.oas.samhsa.gov/2k4/oxycodoneH/oxycodoneH.htm. Accessed February 11, 2008. 9 Birnbaum HG, White AG, Reynolds JL, et al. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: A societal perspective. Clin J Pain. 2006; 22: 667–676. 10 Davis MP, Varga J, Dickerson D, et al. Normal-release and controlled-release oxycodone: Pharmacokinetics, pharmacodynamics, and controversy. Support Care Cancer. 2003; 11: 84–92. 11 Katz N, Fernandez K, Chang A, et al. Internet-based survey of nonmedical prescription opioid use in the United States. Clin J Pain. 2008; 24: 528–535. 12 Rosenblum A, Parrino M, Schnoll SH, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend. 2007; 90: 64–71. 13 Sproule B, Brands B, Li S, et al. Changing patterns in opioid addiction: Characterizing users of oxycodone and other opioids. Can Fam Physician. 2009; 55: 68–69. 14 Drug Abuse Warning Network, Substance Abuse and Mental Health Services Administration. National Estimates of Drug-Related Emergency Department Visits 2006. Rockville , MD : Office of Applied Studies. DHHS Publication No. (SMA) 08-4339, DAWN Series D-30, 2008. 15 Cicero TJ, Surratt H, Inciardi JA, et al. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf. 2007; 16: 827–840. 16 SAMHSA.DASIS Report. Treatment Admissions Involving Narcotic Pain Killers: 2002 Update. Rockville , MD : Office of Applied Studies; 2004. Available at: http://www.oas.samhsa.gov/2k4/painTX/painTX.htm. Accessed June 8, 2009. 17 Marel R, Galea MA, Smith RB, et al. Drug use trends in New York City. Proceedings of the Community Epidemiology Work Group, Vol. II. Bethesda, MD: U.S. Department of Health and Human Services/National Institutes of Health; 2007. 18 United States Census Bureau, Population Division. Annual Estimates of the Population of Combined Statistical Areas: April 1, 2000 to July 1, 2007 (CSV). 2007 Population Estimates. Available at: http://www.census.gov/population/estimates/metro_general/2007/CSA-EST2007-alldata.csv. Accessed September 14, 2009. 19 Hughes A, Sathe N. State Estimates of Substance Use from the 2005–2006 National Surveys on Drug Use and Health. Rockville , MD : Substance Abuse and Mental Health Services Administration, Office of Applied Studies. DHHS Publication No. SMA-08-4311, NSDUH Series H-33; 2008. 20 Substance Abuse and Mental Health Services Administration. Substance Estimates from the 2002–2004 National Surveys on Drug Use and Health. Rockville , MD : Office of Applied Studies; 2006. 21 Katz DA, Hays LR. Adolescent OxyContin abuse. J Am Acad Child Adolesc Psychiatry. 2004; 43: 231–234. 22 Rutkowski BA. Drug Use trends in New York City. Proceedings of the Community Epidemiology Work Group, Vol. II. Bethesda , MD : US Department of Health and Human Services; 2007. 23 SPSS I. SPSS 15.0.0 for Windows. Chicago , IL: IBM©; 2006. 24 Carise D, Dugosh KL, McLellan AT, et al. Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry. 2007; 164: 1750–1756. 25 Back SE, Payne RA, Waldrop AE, et al. Prescription Opioid Aberrant Behaviors: A Pilot Study of Sex Differences. Clin J Pain. 2009; 25: 477–484. 26 Martins SS, Storr CL, Zhuc H, et al. Correlates of extramedical use of OxyContin® versus other analgesic opioids among the US general population. Drug Alcohol Depend. 2009; 99: 58–67. 27 Inciardi JA, Surratt HL, Kurtz SP, et al. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007; 8: 171–183. 28 Office of Alcoholism and Substance Abuse Services. National Illicit Drug Prices, a National Drug Intelligence Center (NDC) Bulletin. Albany , NY : ASAS Street Studies Unit; 2006. 29 Jayawant SS, Balkrishnan R. The controversy surrounding OxyContin abuse: Issues and solutions. Ther Clin Risk Manag. 2005; 1: 77–82. 30 Drug Enforcement Administration. OxyContin®: Pharmaceutical Diversion, 2002. 31 Flugsrud-Breckenridge MR, Gevirtz C, Paul D, et al. Medications of abuse in pain management. Curr Opin Anaesthesiol. 2007; 20: 319–324. 32 Passik SD, Kirsh KL, Donaghy KB, et al. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006; 22: 173–181. Citing Literature Volume20, Issue3May‐June 2011Pages 190-195 ReferencesRelatedInformation
Referência(s)